{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:49:37Z","timestamp":1790660977663,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SAF-94814"],"award-info":[{"award-number":["SAF-94814"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SMN-139150"],"award-info":[{"award-number":["SMN-139150"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.drugalcdep.2018.04.024","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T12:51:33Z","timestamp":1527598293000},"page":"76-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Crude estimates of prescription opioid-related misuse and use disorder populations towards informing intervention system need in Canada"],"prefix":"10.1016","volume":"189","author":[{"given":"Benedikt","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thepikaa","family":"Varatharajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Shield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0005","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1360-0443.2010.03052.x","article-title":"Risk factors for drug dependence among out\u2010patients on opioid therapy in a large US health\u2010care system","volume":"105","author":"Boscarino","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0010","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0015","unstructured":"Canadian Centre on Substance Abuse, 2016. CCENDU Bulletin: The availability of Take-Home Naloxone in Canada. Ottawa, ON: CCSA. Retrieved from http:\/\/www.ccdus.ca\/Eng\/collaboration\/CCENDU\/CCENDU-Drug-Alerts-and-Bulletins\/Pages\/default.aspx. (Accessed February 08, 2018)."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0020","unstructured":"Canadian Institute for Health Information, 2016. Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada. Ottawa, ON. CIHI. Retrieved from https:\/\/secure.cihi.ca\/free_products\/Opioid%20Poisoning%20Report%20%20EN.pdf. (Accessed May 23, 2018)."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0025","unstructured":"Canadian Institute for Health Information, 2017. Opioid-Related Harms in Canada. Ottawa, ON. CIHI. Retrieved from https:\/\/www.cihi.ca\/sites\/default\/files\/document\/opioid-harms-chart-book-en.pdf. (Accessed May 23, 2018)."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S2215-0366(15)00005-X","article-title":"Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study","volume":"2","author":"Degenhardt","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/AJP.0000000000000021","article-title":"The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic non-cancer pain: the role of opioid prescription","volume":"30","author":"Edlund","year":"2014","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0040","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.17269\/cjph.105.4143","article-title":"Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years later","volume":"105","author":"Fischer","year":"2014","journal-title":"Can. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1472-6963-14-90","article-title":"Trends and changes in prescription opioid analgesic dispensing in Canada 2005\u20132012: an update with a focus on recent interventions","volume":"14","author":"Fischer","year":"2014","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0050","first-page":"E659","article-title":"Recent developments in prescription opioid-related dispensing and harm indicators in Ontario, Canada","volume":"18","author":"Fischer","year":"2015","journal-title":"Pain Phys."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13011-016-0055-4","article-title":"Treatment of prescription opioid disorders in Canada: looking at the \u2018other epidemic\u2019?","volume":"11","author":"Fischer","year":"2016","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0060","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1503\/cmaj.160356","article-title":"Effective Canadian policy to reduce harms from prescription opioids: learning from past failures","volume":"188","author":"Fischer","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ypmed.2017.11.001","article-title":"The \u2018fentanyl epidemic\u2019 in Canada\u2013Some cautionary observations focusing on opioid-related mortality","volume":"107","author":"Fischer","year":"2017","journal-title":"Prev. Med."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0070","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/MLR.0000000000000431","article-title":"Geographic variations in prescription opioid dispensations and deaths among women and men in British Columbia, Canada","volume":"53","author":"Gladstone","year":"2015","journal-title":"Med. Care."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0075","series-title":"Behind the prescriptions: A snapshot of opioid use across all Ontarians","author":"Gomes","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0080","series-title":"Canadian Alcohol and Drug Use Monitoring Survey (CADUMS)","author":"Health Canada","year":"2014"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0085","series-title":"Canadian Alcohol and Drug Use Monitoring Survey (CTADS)","author":"Health Canada","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0090","series-title":"Federal Action on Opioids","author":"Health Canada","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0095","series-title":"Infographic: Apparent Opioid-related Deaths in Canada in 2016 (August 2017)","author":"Health Canada","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0100","series-title":"Supervised Consumption Sites: Status of Applications","author":"Health Canada","year":"2018"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0105","unstructured":"Health Quality Ontario, 2017. 9 Million Prescriptions: What we know about the growing use of prescription opioids in Ontario. Toronto, ON: Queen\u2019s Printer for Ontario. Retrieved from http:\/\/www.hqontario.ca\/portals\/0\/Documents\/system-performance\/9-million-prescriptions-en.pdf. (Accessed May 23, 2018)."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0110","unstructured":"Health Quality Ontario, 2018. Starting on Opioids: Opioid prescribing patterns in Ontario by family doctors, surgeons, and dentists, for people starting to take opioids. Toronto, ON: Queen\u2019s Printer for Ontario. Retrieved from http:\/\/www.hqontario.ca\/portals\/0\/Documents\/system-performance\/starting-on-opioids-en.pdf. (March 01, 2018)."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0115","unstructured":"International Narcotics Control Board, 2007. Narcotic Drugs - Estimated World Requirements for 2007 (Statistics for 2005). New York: United Nations. Retrieved from https:\/\/www.incb.org\/documents\/Narcotic-Drugs\/Technical-Publications\/2006\/Narcotics_2006_ebook.pdf. (Accessed March 01, 2018)."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0120","unstructured":"International Narcotics Control Board, 2017. Narcotic Drugs - Estimated World Requirements for 2017 (Statistics for 2015). New York: United Nations. Retrieved from https:\/\/www.incb.org\/documents\/Narcotic-Drugs\/Technical-Publications\/2016\/Narcotic_Drugs_Publication_2016.pdf. (Accessed May 23, 2018)."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0125","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0130","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1503\/cmaj.131723","article-title":"The management of opioid dependence during pregnancy in rural and remote settings","volume":"187","author":"Jumah","year":"2015","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0135","series-title":"Monte Carlo Methods","author":"Kalos","year":"2008"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0140","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1360-0443.2012.04005.x","article-title":"Development of dependence following treatment with opioid analgesics for pain relief: a systematic review","volume":"108","author":"Minozzi","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0145","doi-asserted-by":"crossref","first-page":"e1340","DOI":"10.7717\/peerj.1340","article-title":"Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12\u201321 year olds in the United States using meta-analysis, 2002\u201313","volume":"3","author":"Parker","year":"2015","journal-title":"Peer J."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0150","series-title":"Monte Carlo Methods","author":"Robert","year":"2004"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0155","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4088\/JCP.15m10386","article-title":"Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States","volume":"77","author":"Saha","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0160","doi-asserted-by":"crossref","first-page":"ES67","DOI":"10.36076\/ppj.2012\/15\/ES67","article-title":"Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse","volume":"15","author":"Sehgal","year":"2012","journal-title":"Pain Phys."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0165","unstructured":"Statistics Canada, 2017. Table 051-0001 - Estimates of population, by age group and sex for July 1, Canada, provinces and territories annual (persons unless otherwise noted). Retrieved from: http:\/\/www5.statcan.gc.ca\/cansim\/a26?lang=eng&retrLang=eng&id=0510001&&pattern=&stByVal=1&p1=1&p2=37&tabMode=dataTable&csid=. (Accessed February 08 2018)."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0170","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0175","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116820","article-title":"The global burden of mental, neurological and substance use disorders: an analysis from the global burden of disease study 2010","volume":"10","author":"Whiteford","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/SAR.S18969","article-title":"Differences in onset and abuse\/dependence episodes between prescription opioids and heroin: results from the national epidemiologic survey on alcohol and related conditions","volume":"2","author":"Wu","year":"2011","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.drugalcdep.2018.04.024_bib0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"Wu","year":"2016","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618302904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618302904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:55:10Z","timestamp":1759827310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618302904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":38,"alternative-id":["S0376871618302904"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.024","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crude estimates of prescription opioid-related misuse and use disorder populations towards informing intervention system need in Canada","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}